Perfil
Sheldon Sloan is Chief Medical Officer at Spyre Therapeutics, Inc. since 2024.
Formerly, Chief Medical Officer at Abivax SA from 2023 to 2024.
Education includes graduate degree from the University of Pennsylvania, undergraduate degree from Illinois Urbana Champaign University of, and doctorate from Rush Medical College.
Cargos activos de Sheldon Sloan
| Empresas | Cargo | Inicio |
|---|---|---|
| SPYRE THERAPEUTICS, INC. | Director Técnico/Científico/I+D | 01/10/2024 |
Antiguos cargos conocidos de Sheldon Sloan.
| Empresas | Cargo | Fin |
|---|---|---|
| ABIVAX | Director Técnico/Científico/I+D | 15/07/2024 |
Formación de Sheldon Sloan.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 4 |
|---|---|
Spyre Therapeutics, Inc.
Spyre Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biotechnology company | Health Technology |
University of Pennsylvania
University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Rush Medical College
Rush Medical College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Abivax SA
Abivax SA Pharmaceuticals: OtherHealth Technology Operates biotechnology company which develops therapeutics that harness the body’s natural regulatory mechanisms | Health Technology |
- Bolsa de valores
- Insiders
- Sheldon Sloan
















